{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T14:04:36Z","timestamp":1778162676316,"version":"3.51.4"},"reference-count":25,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,1,17]],"date-time":"2020-01-17T00:00:00Z","timestamp":1579219200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003977","name":"Israel Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003977","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2019.01566","type":"journal-article","created":{"date-parts":[[2020,1,17]],"date-time":"2020-01-17T04:11:40Z","timestamp":1579234300000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["The Hyperpolarization-Activated Cyclic-Nucleotide-Gated Channel Blocker Ivabradine Does Not Prevent Arrhythmias in Catecholaminergic Polymorphic Ventricular Tachycardia"],"prefix":"10.3389","volume":"10","author":[{"given":"Hanna","family":"Bueno-Levy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Weisbrod","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dor","family":"Yadin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiraz","family":"Haron-Khun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asher","family":"Peretz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edith","family":"Hochhauser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Arad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard","family":"Attali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2020,1,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1111\/anec.12024","article-title":"A family with recurrent sudden death and no clinical clue","volume":"17","author":"Arad","year":"2012","journal-title":"Ann. Noninvasive Electrocardiol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"H1259","DOI":"10.1152\/ajpheart.00076.2016","article-title":"Dynamics of PKA phosphorylation and gain of function in cardiac pacemaker cells: a computational model analysis","volume":"310","author":"Behar","year":"2016","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"e53132","DOI":"10.1371\/journal.pone.0053132","article-title":"Identification of the molecular site of ivabradine binding to HCN4 channels","volume":"8","author":"Bucchi","year":"2013","journal-title":"PloS One"},{"key":"B4","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1097\/HCO.0b013e3283459893","article-title":"Genetics of sudden cardiac death syndromes","volume":"26","author":"Chopra","year":"2011","journal-title":"Curr. Opin. Cardiol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1111\/bcpt.12829","article-title":"Ivabradine Reduces Digitalis-induced Ventricular Arrhythmias","volume":"121","author":"Frommeyer","year":"2017","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1111\/1440-1681.12790","article-title":"Antiarrhythmic properties of ivabradine in an experimental model of Short-QT- Syndrome","volume":"44","author":"Frommeyer","year":"2017","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1093\/eurheartj\/eht452","article-title":"Calsequestrin 2 deletion causes sinoatrial node dysfunction and atrial arrhythmias associated with altered sarcoplasmic reticulum calcium cycling and degenerative fibrosis within the mouse atrial pacemaker complex1","volume":"36","author":"Glukhov","year":"2015","journal-title":"Eur. Heart J."},{"key":"B8","doi-asserted-by":"publisher","first-page":"415","DOI":"10.15252\/emmm.201606937","article-title":"SK4 K+ channels are therapeutic targets for the treatment of cardiac arrhythmias","volume":"9","author":"Haron-Khun","year":"2017","journal-title":"EMBO Mol. Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1161\/CIRCULATIONAHA.108.829267","article-title":"Incidence and risk factors of arrhythmic events in catecholaminergic polymorphic ventricular tachycardia","volume":"119","author":"Hayashi","year":"2009","journal-title":"Circulation"},{"key":"B10","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.hrthm.2017.10.008","article-title":"Accentuated vagal antagonism paradoxically increases ryanodine receptor calcium leak in long-term exercised Calsequestrin2 knockout mice","volume":"15","author":"Ho","year":"2018","journal-title":"Heart Rhythm."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1016\/j.hrthm.2010.07.004","article-title":"Optimizing catecholaminergic polymorphic ventricular tachycardia therapy in calsequestrin-mutant mice","volume":"7","author":"Katz","year":"2010","journal-title":"Heart Rhythm."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1016\/j.jacc.2017.08.038","article-title":"The Clinical Use of Ivabradine","volume":"70","author":"Koruth","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/j.hrthm.2017.03.025","article-title":"Viral delivered gene therapy to treat catecholaminergic polymorphic ventricular tachycardia (CPVT2) in mouse models","volume":"14","author":"Kurtzwald-Josefson","year":"2017","journal-title":"Heart Rhythm."},{"key":"B14","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.yjmcc.2009.03.022","article-title":"What keeps us ticking: a funny current, a calcium clock, or both","volume":"47","author":"Lakatta","year":"2009","journal-title":"J. Mol. Cell Cardiol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1253\/circj.CJ-16-0326","article-title":"Catecholaminergic polymorphic ventricular tachycardia","volume":"80","author":"Lieve","year":"2016","journal-title":"Circ. J."},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.115.001813","article-title":"hERG potassium channel blockade by the HCN channel inhibitor bradycardic agent ivabradine","volume":"4","author":"Melgari","year":"2015","journal-title":"J. Am. Heart Assoc."},{"key":"B17","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1111\/j.1582-4934.2011.01476.x","article-title":"Cardiomyocytes generated from CPVTD307H patients are arrhythmogenic in response to beta-adrenergic stimulation","volume":"16","author":"Novak","year":"2012","journal-title":"J. Cell Mol. Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1161\/CIRCRESAHA.110.226845","article-title":"Inherited Dysfunction of Sarcoplasmic Reticulum Ca2+ Handling and Arrhythmogenesis","volume":"108","author":"Priori","year":"2011","journal-title":"Circ. Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1161\/01.CIR.0000020013.73106.D8","article-title":"Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia","volume":"106","author":"Priori","year":"2002","journal-title":"Circulation"},{"key":"B20","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1097\/HCO.0000000000000360","article-title":"Catecholaminergic polymorphic ventricular tachycardia: a model for genotype-specific therapy","volume":"32","author":"Roston","year":"2017","journal-title":"Curr. Opin. Cardiol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1172\/JCI31080","article-title":"Calsequestrin 2 (CASQ2) mutations increase expression of calreticulin and ryanodine receptors, causing catecholaminergic polymorphic ventricular tachycardia","volume":"117","author":"Song","year":"2007","journal-title":"J. Clin. Invest."},{"key":"B22","doi-asserted-by":"publisher","first-page":"9769","DOI":"10.1073\/pnas.1505670112","article-title":"Burst pacemaker activity of the sinoatrial node in sodium-calcium exchanger knockout mice","volume":"112","author":"Torrente","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1111\/pace.13446","article-title":"Efficacy of ivabradine to control ventricular arrhythmias in catecholaminergic polymorphic ventricular tachycardia","volume":"41","author":"Vaksmann","year":"2018","journal-title":"Pacing Clin. Electrophysiol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"E1685","DOI":"10.1073\/pnas.1221022110","article-title":"SK4 Ca2+ activated K+ channel is a critical player in cardiac pacemaker derived from human embryonic stem cells","volume":"110","author":"Weisbrod","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B25","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.yjmcc.2013.04.026","article-title":"New evidence for coupled clock regulation of the normal automaticity of sinoatrial nodal pacemaker cells: bradycardic effects of ivabradine are linked to suppression of intracellular Ca(2)(+) cycling","volume":"62","author":"Yaniv","year":"2013","journal-title":"J. Mol. Cell Cardiol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2019.01566\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,17]],"date-time":"2020-01-17T04:11:42Z","timestamp":1579234302000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2019.01566\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,17]]},"references-count":25,"alternative-id":["10.3389\/fphar.2019.01566"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2019.01566","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,17]]},"article-number":"1566"}}